glp-1 drugs pancreatitis Adverse effects of class drugs. Gastrointestinal issues are Studies examining GLP-1 RA therapy

In one study, women with PCOS who hadnt seen results from diet and exercise alone started weekly semaglutide injections

Associations of concurrent hypertension and type 2 diabetes with mortality outcomes: a prospective study of U.S

Thus, GLP-1 receptor agonists can stabilize the atherosclerotic plaques, provide protection against MACEs, and lower blood pressure, which all produce beneficial cardiovascular effects for the patient

Semaglutide and tirzepatide were FDA-approved in 2021 as injectable treatments for weight loss, under the names Wegovy and Mounjaro

However, it is essential to monitor progress and make adjustments as needed